Moreover, in patients with axSpA and IBD, levels of serum markers of endothelial dysfunction differed from those in controls; specifically, compared to controls, patients with axSpA and IBD had increased serum IL-18 and ADMA levels and decreased serum fetuin-A level. This evidence concerns the gene IL18 and inflammatory bowel disease.